COLLAGEN IN OSTEOARTHRITIC CARTILAGE
骨关节炎软骨中的胶原蛋白
基本信息
- 批准号:3151006
- 负责人:
- 金额:$ 14.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-03-15 至 1986-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The proposed research is directed toward understanding 1) the factors which
modulate the differentiated state of chondrocytes, and 2) the hormonal
regulation or cartilage matrix synthesis. We have observed that
dedifferentiated chondrocytes will return to the differentiated state if
changed to spherical shape in agarose suspension culture. Cytoskeletal
involvement in phenotypic switching is indicated because dedifferentiated
monolayer chondrocytes will reexpress the differentiated collagen phenotype
after treatment with the microfilament-disruptive drug, cytochalasin B. We
will document and expand this information on a microfilament-dependent
pathway for gene regulation in chondrocytes. We have hypothesized that the
increased rate of proteoglycan (PG) and collagen synthesis (8-fold) that
occurs during in vitro culture of articular cartilage slices is due to an
increase in the number of somatomedin receptors per cell. Following an
initial lack of serum dose response, original chondrocytes and their
progeny in agarose, monolayer, and slice cultures become dose responsive as
measured by PG and DNA synthesis. Radiolabeled growth factors will be used
to probe for parallel increases in receptor number/cell. If we can
understand the mechanism of this increase in cellular responsiveness to
serum we may be able to increase matrix synthesis in osteoarthritis and
greatly decrease the cartilage destruction that follows proteoglycan
depletion. These studies will be performed with rabbit humeral articular
cartilage and chondrocytes. Collagen phenotypes will be routinely
determined by SDS electrophoresis and 2-D CNBr peptide maps of isolated
collagens. Understanding the mechanism that stabilize the chondrocyte
phenotype and enhance matrix synthesis may facilitate the design of
therapeutic strategies that stimulate resistance to the initiation and
progression of osteoarthritis.
提出的研究旨在了解1)因素
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coordinate regulation of type IX and type II collagen synthesis during growth of chick chondrocytes in retinoic acid or 5-bromo-2'-deoxyuridine.
在视黄酸或 5-溴-2-脱氧尿苷中鸡软骨细胞生长过程中协调 IX 型和 II 型胶原合成的调节。
- DOI:
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Yasui,N;Benya,PD;Nimni,ME
- 通讯作者:Nimni,ME
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul David Benya其他文献
Paul David Benya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul David Benya', 18)}}的其他基金
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models
siRNA 抑制纤维蛋白基质皮肤等效小鼠模型中的瘢痕疙瘩纤维化
- 批准号:
8452052 - 财政年份:2012
- 资助金额:
$ 14.24万 - 项目类别:
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models
siRNA 抑制纤维蛋白基质皮肤等效小鼠模型中的瘢痕疙瘩纤维化
- 批准号:
8256619 - 财政年份:2012
- 资助金额:
$ 14.24万 - 项目类别:
相似海外基金
The repair of cartilage disorder with parathyroid hormone related peptide.
甲状旁腺激素相关肽修复软骨损伤。
- 批准号:
08457396 - 财政年份:1996
- 资助金额:
$ 14.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)